Protalix BioTherapeutics
PLX
PLX
25 hedge funds and large institutions have $18.4M invested in Protalix BioTherapeutics in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 6 closing their positions.
Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
5
Closed
6
Calls
$658K
Puts
$93K
Net Calls
+$565K
Net Calls Change
-$571K
Top Buyers
Top Sellers
1 |
UOC
1
UBS O'Connor
Chicago,
Illinois
|
$1.16M |
2 |
2
Jane Street
New York
|
$57K |
3 |
3
Walleye Capital
New York
|
$0 |
4 |
4
Renaissance Technologies
New York
|
$1.9M |
5 |
5
Walleye Trading
New York
|
$0 |